Carl-Gustaf A. Stenvall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Carl-Gustaf A. Stenvall has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Diana M. Toivola
InFLAMES Flagship University of Turku and Åbo Akademi University Turku Finland
3 shared publications - Lauri Polari
Cell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi University
2 shared publications - Antti Saraste
Heart Center, Turku University Hospital, Turku, Finland
1 shared publication - Fanny Lindholm
Institute of Biomedicine University of Turku Turku Finland
1 shared publication - Fu-Ping Zhang
Institute of Biomedicine University of Turku Turku Finland
1 shared publication - Gun West
Institute of Biomedicine University of Turku Turku Finland
1 shared publication
Latest Publications
- Open Access
- 14 November 2026
- Published by Wiley in The Journal of Pathology
The p. Ser143Pro lamin A/C mutation leads to dilated cardiomyopathy and activates the unfolded protein response pathway in a knock‐in mouse model
Dilated cardiomyopathy (DCM) is characterized by progressive ventricular dilation, systolic dysfunction, and an increased risk of arrythmias and sudden cardiac arrest. Variants in the LMNA gene, which encodes the nuclear lamins A and C, have been linked to the familial form of the disease and the founder variant p.Ser143Pro is particularly common among Finnish patients with DCM. To elucidate the complex and poorly understood pathogenic mechanisms behind LMNA ‐related DCM, we generated a mouse model carrying the p.Ser143Pro mutation in the Lmna gene. All genetically modified mice appeared normal at birth. However, based on echocardiography, necropsy, natriuretic peptide B ( Nppb ) expression levels, and histopathological data, homozygous males developed progressive left ventricular dilatation, myocardial fibrosis, and cardiac failure after 6 months of age, with all succumbing before 10 months. A reduced disease penetrance was observed in heterozygous male and homozygous female mice, with one‐year survival rates of 40% and 60%, respectively. No signs of skeletal myopathy were observed in mice carrying the mutation. Whole‐transcriptome RNA sequencing analysis of left ventricular cardiac tissue from asymptomatic two‐month‐old homozygous male mice revealed an upregulation of classical heart failure markers, such as natriuretic peptide A ( Nppa ) and myosin heavy chain 7 ( Myh7 ), and an elevated unfolded protein response signaling, as shown by elevated DNA damage inducible transcript 3 ( Ddit3 ), BAG cochaperone 3 ( Bag3 ) and CCAAT enhancer binding protein beta ( Cebpb ) levels. In conclusion, p.Ser143Pro‐ Lmna mice closely mimic the clinical phenotype observed in patients with the p.Ser143Pro LMNA variant and offer a valuable in vivo model for investigating the underlying pathogenic mechanisms of LMNA ‐related DCM. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
- 14 November 2026
- Published by Wiley in The Journal of Pathology
Open AccessThe p. Ser143Pro lamin A/C mutation leads to dilated cardiomyopathy and activates the unfolded protein response pathway in a knock‐in mouse model
Dilated cardiomyopathy (DCM) is characterized by progressive ventricular dilation, systolic dysfunction, and an increased risk of arrythmias and sudden cardiac arrest. Variants in the LMNA gene, which encodes the nuclear lamins A and C, have been linked to the familial form of the disease and the founder variant p.Ser143Pro is particularly common among Finnish patients with DCM. To elucidate the complex and poorly understood pathogenic mechanisms behind LMNA ‐related DCM, we generated a mouse model carrying the p.Ser143Pro mutation in the Lmna gene. All genetically modified mice appeared normal at birth. However, based on echocardiography, necropsy, natriuretic peptide B ( Nppb ) expression levels, and histopathological data, homozygous males developed progressive left ventricular dilatation, myocardial fibrosis, and cardiac failure after 6 months of age, with all succumbing before 10 months. A reduced disease penetrance was observed in heterozygous male and homozygous female mice, with one‐year survival rates of 40% and 60%, respectively. No signs of skeletal myopathy were observed in mice carrying the mutation. Whole‐transcriptome RNA sequencing analysis of left ventricular cardiac tissue from asymptomatic two‐month‐old homozygous male mice revealed an upregulation of classical heart failure markers, such as natriuretic peptide A ( Nppa ) and myosin heavy chain 7 ( Myh7 ), and an elevated unfolded protein response signaling, as shown by elevated DNA damage inducible transcript 3 ( Ddit3 ), BAG cochaperone 3 ( Bag3 ) and CCAAT enhancer binding protein beta ( Cebpb ) levels. In conclusion, p.Ser143Pro‐ Lmna mice closely mimic the clinical phenotype observed in patients with the p.Ser143Pro LMNA variant and offer a valuable in vivo model for investigating the underlying pathogenic mechanisms of LMNA ‐related DCM. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
- Open Access
Genetically induced mouse model for colon-specific epithelial cell tumorigenesis driven by loss of K8 and Apc
Loss of keratin 8 (K8) has been shown to increase susceptibility towards colonocyte hyperproliferation and tumorigenesis. However, most colorectal cancer (CRC) mouse models require carcinogen, develop small intestinal tumors or have long latency period. The aim was to establish a genetic, colon-specific and more human like CRC model driven by loss of K8 and Apc. Colon epithelium specific targeting using the CDX2P-CreER T2 mice was used to generate K8 flox/flox ; CDX2P-CreER T2 and K8 flox/flox ; CDX2P-CreER T2 ; Apc flox/+ mice. Body weight and stool consistency were monitored, and colon was analyzed for tumor burden and histopathology. Keratin expression, inflammation, and proliferation were assessed using immunoblotting and immunofluorescence analysis. This data was compared to K8 expression analysis in patients with CRC using UALCAN database. K8 downregulation in adult K8 flox/flox ; CDX2P-CreER T2 mice triggers mild diarrhea and leads to loss of K8 and reduced partner keratin levels in a mosaic pattern in the colonic epithelium, while ileal K8 protein levels are unchanged. K8-negative colon areas display increased crypt loss and more MPO+ cells predominantly in the proximal colon. Increased colonocyte proliferation is observed as increased percentage of Ki67+ cells and lower IL-22BP protein levels throughout the colon. These mice with additional monoallelic Apc inactivation show increased colon tumor formation. In colon adenocarcinoma patients, K8 expression is decreased independent of disease type and stage, age or gender. New genetic and colon-specific mouse model with loss of K8 and Apc adequately resembles human CRC. This study also highlights a role of colonocyte K8 in maintaining colon epithelial integrity and protecting against colon tumorigenesis.
Open AccessGenetically induced mouse model for colon-specific epithelial cell tumorigenesis driven by loss of K8 and Apc
Loss of keratin 8 (K8) has been shown to increase susceptibility towards colonocyte hyperproliferation and tumorigenesis. However, most colorectal cancer (CRC) mouse models require carcinogen, develop small intestinal tumors or have long latency period. The aim was to establish a genetic, colon-specific and more human like CRC model driven by loss of K8 and Apc. Colon epithelium specific targeting using the CDX2P-CreER T2 mice was used to generate K8 flox/flox ; CDX2P-CreER T2 and K8 flox/flox ; CDX2P-CreER T2 ; Apc flox/+ mice. Body weight and stool consistency were monitored, and colon was analyzed for tumor burden and histopathology. Keratin expression, inflammation, and proliferation were assessed using immunoblotting and immunofluorescence analysis. This data was compared to K8 expression analysis in patients with CRC using UALCAN database. K8 downregulation in adult K8 flox/flox ; CDX2P-CreER T2 mice triggers mild diarrhea and leads to loss of K8 and reduced partner keratin levels in a mosaic pattern in the colonic epithelium, while ileal K8 protein levels are unchanged. K8-negative colon areas display increased crypt loss and more MPO+ cells predominantly in the proximal colon. Increased colonocyte proliferation is observed as increased percentage of Ki67+ cells and lower IL-22BP protein levels throughout the colon. These mice with additional monoallelic Apc inactivation show increased colon tumor formation. In colon adenocarcinoma patients, K8 expression is decreased independent of disease type and stage, age or gender. New genetic and colon-specific mouse model with loss of K8 and Apc adequately resembles human CRC. This study also highlights a role of colonocyte K8 in maintaining colon epithelial integrity and protecting against colon tumorigenesis.
- Open Access
- 24 December 2021
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (1) , 1-17
Targeted deletion of keratin 8 in intestinal epithelial cells disrupts tissue integrity and predisposes to tumorigenesis in the colon
Keratin 8 (K8) is the main intestinal epithelial intermediate filament protein with proposed roles for colonic epithelial cell integrity. Here, we used mice lacking K8 in intestinal epithelial cells (floxed K8 and Villin-Cre1000 and Villin-CreERt2) to investigate the cell-specific roles of intestinal epithelial K8 for colonocyte function and pathologies. Intestinal epithelial K8 deletion decreased K8 partner proteins, K18–K20, 75–95%, and the remaining keratin filaments were located at the colonocyte apical regions with type II K7, which decreased 30%. 2-Deoxy-2-[18F]-fluoroglucose positron emission tomography in vivo imaging identified a metabolic phenotype in the lower gut of the conditional K8 knockouts. These mice developed intestinal barrier leakiness, mild diarrhea, and epithelial damage, especially in the proximal colon. Mice exhibited shifted differentiation from enterocytes to goblet cells, displayed longer crypts and an increased number of Ki67 + transit-amplifying cells in the colon. Significant proproliferative and regenerative signaling occurred in the IL-22, STAT3, and pRb pathways, with minor effects on inflammatory parameters, which, however, increased in aging mice. Importantly, colonocyte K8 deletion induced a dramatically increased sensitivity to azoxymethane-induced tumorigenesis. In conclusion, intestinal epithelial K8 plays a significant role in colonocyte epithelial integrity maintenance, proliferation regulation and tumor suppression. Graphical abstract
- 24 December 2021
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (1) , 1-17
Open AccessTargeted deletion of keratin 8 in intestinal epithelial cells disrupts tissue integrity and predisposes to tumorigenesis in the colon
Keratin 8 (K8) is the main intestinal epithelial intermediate filament protein with proposed roles for colonic epithelial cell integrity. Here, we used mice lacking K8 in intestinal epithelial cells (floxed K8 and Villin-Cre1000 and Villin-CreERt2) to investigate the cell-specific roles of intestinal epithelial K8 for colonocyte function and pathologies. Intestinal epithelial K8 deletion decreased K8 partner proteins, K18–K20, 75–95%, and the remaining keratin filaments were located at the colonocyte apical regions with type II K7, which decreased 30%. 2-Deoxy-2-[18F]-fluoroglucose positron emission tomography in vivo imaging identified a metabolic phenotype in the lower gut of the conditional K8 knockouts. These mice developed intestinal barrier leakiness, mild diarrhea, and epithelial damage, especially in the proximal colon. Mice exhibited shifted differentiation from enterocytes to goblet cells, displayed longer crypts and an increased number of Ki67 + transit-amplifying cells in the colon. Significant proproliferative and regenerative signaling occurred in the IL-22, STAT3, and pRb pathways, with minor effects on inflammatory parameters, which, however, increased in aging mice. Importantly, colonocyte K8 deletion induced a dramatically increased sensitivity to azoxymethane-induced tumorigenesis. In conclusion, intestinal epithelial K8 plays a significant role in colonocyte epithelial integrity maintenance, proliferation regulation and tumor suppression. Graphical abstract